Drug Topics
OCTOBER 27, 2022
Drug Topics® is joined by Dr. Alex Capano, Chief Science Officer at Ananda professional to discuss what CBD is used for mental health, where research should go next, and how to ensure that patients are getting effective CBD products.
PhRMA
OCTOBER 26, 2022
A survey of more than 5,000 Americans conducted with Ipsos found that nearly 40% of insured Americans struggle to understand what their health insurance covers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
OCTOBER 26, 2022
The Stanford researcher and biotech entrepreneur discusses how click and bioorthogonal chemistry could revolutionize drug development.
IDStewardship
OCTOBER 28, 2022
In this article a PGY2 Infectious Diseases Pharmacy Resident discusses social media as a resource for pharmacy residency recruitment, providing insights for both programs and candidates. . Authored by: Hunter O. Rondeau, Pharm.D. Article Posted 28 October 2022. Virtual recruitment for post-graduate residency programs continues to find its place, especially now with the upcoming in-person Midyear after two years of an “online-only” environment.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
OCTOBER 25, 2022
In a recent poll, only 1 in 5 parents believed it is unsafe for children to take medicine past its expiration date, while many did not know how to properly dispose medicine.
PhRMA
OCTOBER 27, 2022
PhRMA is proud to announce the release of its first ever chart pack on health equity. This chart pack contains information on health equity in three sections: (1) A Snapshot of Health Disparities in America, (2) Inequities in Access to Screenings and Medicines Allow Health Disparities to Persist, and (3) PhRMA’s Commitment to Building a More Equitable Health Care System for All.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
OCTOBER 26, 2022
Research suggests that positron emission tomography scans are effective at detecting early and late Hodgkin’s lymphoma, and the results could help manage and reduce toxicity from current chemotherapies.
Drug Topics
OCTOBER 26, 2022
The Flip the Pharmacy program provides tools to pharmacy technicians and non-pharmacy support staff Mitchell’s Drug Stores to help provide patient care.
PhRMA
OCTOBER 24, 2022
The bipartisan Bayh-Dole Act created a framework for researchers receiving federal funds to patent and license their inventions to companies for further development and commercialization. This benefits innovators across many sectors.
PharmaVoice
OCTOBER 25, 2022
The company's head of U.S. and Canadian operations explains how the company is evolving its game plan after 100 years in the insulin space.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
OCTOBER 28, 2022
Modifications related to final product verifications, immunizations, and remote work loom on the horizon for 2023.
Drug Topics
OCTOBER 25, 2022
How on pharmacy helps patients with chronic concerns like diabetes.
Pharmaceutical Technology
OCTOBER 28, 2022
Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. Considering the low chances of success, with only 10% of drug candidates making it into clinical development, pharma companies must prevent the increased erosion of profit margins.
PharmaVoice
OCTOBER 25, 2022
The company’s co-founder and head of R&D on how it’s using synthetic mRNA to create “smarter” therapies that could provide cures for cancer and more.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
OCTOBER 28, 2022
In a panel, pharmacy technicians discuss the future of pharmacy technicians in United States, Portugal, and the United Kingdom.
Drug Topics
OCTOBER 28, 2022
State of Skin Sensitivity Report raises awareness of the causes of skin sensitivity and its effect on the mind.
pharmaphorum
OCTOBER 28, 2022
In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination. Join us on Wednesday 23rd November at 12:30 GMT / 13:30 CET / 7:30 am EST as the panel discuss how the Innovative Medicines Fund works, what the implications are for industry organisations in securing fu
PharmaVoice
OCTOBER 27, 2022
Biogen and Eisai's new Alzheimer's drug is wowing investigators, and it might help the companies get past previous failures.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
OCTOBER 27, 2022
Although clinicians cited lack of time as a reason for not using patient-reported outcomes, patients with HIV viewed their use very positively.
Drug Topics
OCTOBER 24, 2022
According to NEXGEL, the patch is expected be available for ophthalmologists to offer to their patients in the first half of 2023.
pharmaphorum
OCTOBER 25, 2022
Novartis has abandoned development of its drug to treat presbyopia, a common age-related loss of near distance vision, after it failed a phase 2b trial. The eyedrop formulation of UNR844 (lipoic acid/choline ester chloride) was acquired as part of the group’s buyout of privately-held ophthalmology biotech Encore Vision for $375 million upfront in 2017, and was designed to work by restoring the elasticity of the eye’s lens that declines with age.
PharmaVoice
OCTOBER 28, 2022
Top women execs speak to the leadership skills they are embracing as the industry adjusts to a new normal.
Pharmacy Times
OCTOBER 25, 2022
News research results in Zambia also find that early intervention in the form of antiretroviral therapies and better nutrition may help close the gap.
Drug Topics
OCTOBER 22, 2022
To sufficiently address HIV, stakeholders across the health care spectrum must come together.
STAT
OCTOBER 26, 2022
Who gets better medical care in the United States: “addicts,” or “people with substance use disorders”? The terms, of course, mean functionally the same thing. But in the field of addiction medicine, the question presents something of a crisis. Even as drugs and alcohol claim 200,000 lives each year, many who seek addiction treatment are greeted by the harsh, stigmatizing labels that many Americans don’t think twice about: Words like addict, alcoholic, junkie,
PharmaVoice
OCTOBER 24, 2022
Why a ‘very exciting’ trial of the therapy in lupus patients could swing the door open to new studies in autoimmune diseases.
Pharmacy Times
OCTOBER 25, 2022
Patients with synchronous liver metastases from colorectal cancer have been found to have worse outcomes than those with metachronous liver metastases.
Drug Topics
OCTOBER 24, 2022
Turn your pharmacy into a point-of-care testing site.
Drug Store News
OCTOBER 26, 2022
The retailer is using technology to take the guesswork out of gifting.
PharmaVoice
OCTOBER 24, 2022
In Amgen's 2022 Biosimilars Trend Report, the company tracks the progress and potential of the copycat drugs as they reach a pivotal moment.
Pharmacy Times
OCTOBER 28, 2022
Pharmacists can remind parents to have an EpiPen on hand and to carefully review candy after trick-or-treating.
Drug Topics
OCTOBER 24, 2022
Flip the Pharmacy helped this Jonesboro, Arkansas, pharmacy go from a traditional dispensing one to a pharmacy offering robust clinical services.
pharmaphorum
OCTOBER 25, 2022
AstraZeneca’s IL-5 inhibitor Fasenra is already making blockbuster sales from its use in eosinophilic asthma, but the drugmaker’s efforts to expand its label keep running into difficulties. Earlier this year, the FDA rejected AZ’s application for Fasenra (benralizumab) as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) with a request for more data.
Expert insights. Personalized for you.
503 
Let's personalize your content